Vext Science Reports Corrected Q3 2025 Financials with Strong Revenue Growth

Vext Science ( (TSE:VEXT) ) has provided an announcement.

Vext Science, Inc. reported corrected financial results for Q3 2025, revealing a revenue increase of 41% year-over-year to $12.7 million, driven by expanded operations in Ohio and steady performance in Arizona. Despite earlier inaccuracies in financial metrics, the company demonstrated strong operational discipline, with a year-to-date operating cash flow of $8.5 million. Vext plans to continue expanding its Ohio dispensary footprint and anticipates improved cash flow in Q4, positioning itself for sustainable growth and long-term shareholder value.

The most recent analyst rating on (TSE:VEXT) stock is a Hold with a C$0.20 price target. To see the full list of analyst forecasts on Vext Science stock, see the TSE:VEXT Stock Forecast page.

Spark’s Take on TSE:VEXT Stock

According to Spark, TipRanks’ AI Analyst, TSE:VEXT is a Neutral.

Vext Science’s overall stock score is primarily influenced by its financial performance and earnings call insights. While the company shows strong revenue growth and improving cash flow, profitability challenges and market pressures in Arizona weigh heavily. Technical indicators suggest bearish momentum, and the negative P/E ratio reflects market caution. The earnings call provided positive guidance, but operational challenges remain.

To see Spark’s full report on TSE:VEXT stock, click here.

More about Vext Science

Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. The company focuses on expanding its retail footprint in these states, aiming to capture growth in the adult-use cannabis market.

Average Trading Volume: 48,429

Technical Sentiment Signal: Buy

Current Market Cap: C$60.68M

For detailed information about VEXT stock, go to TipRanks’ Stock Analysis page.